Ocaliva (obeticholic acid)

pCPA File Number: 20983

Negotiation Status:

Concluded with an LOI

Indication(s):

Primary biliary cholangitis

Sponsor/Manufacturer:

Intercept Pharma Canada

CDA-AMC Project Number:

SR0509-000

pCPA Engagement Letter Issued:

2017-12-08

Negotiation Process Concluded:

2018-06-27